Dr. Nathaniel S. Treister is the Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital (BWH) and the Clinical Director for Oral Medicine and Oral Oncology at Dana-Farber Cancer Institute. Dr. Treister also serves as an Associate Surgeon at Dana-Farber Brigham Cancer Center and is a consulting staff member of Boston Children’s Hospital. He is an Associate Professor at Harvard School of Dental Medicine.
Dr. Treister earned his dental degree from the University of Pennsylvania School of Dental Medicine. He completed an oral medicine residency at Harvard School of Dental Medicine/BWH and is board certified in oral medicine. Dr. Treister’s primary clinical interests include oral mucosal diseases and oral complications of cancer therapy and, in particular, graft-versus-host disease.
Dr. Treister’s research is primarily focused in the field of oral complications related to cancer therapies, with particular interest in hematopoietic cell transplantation, mucositis and graft-versus-host disease. The goal of his research is to better understand the underlying pathology of these oral complications and how best to manage and improve outcomes. His work has been supported by the Children’s Oncology Group and the National Institute of Dental and Craniofacial Research as well as through internal institutional funding.
